# Microbiotica

**Source:** https://www.startuphub.ai/startups/microbiotica
**Profile type:** Startup

> British clinical-stage biopharma company developing a pipeline of orally-dosed, precision microbiome medicines.

## About

Microbiotica is a clinical-stage biopharmaceutical company specializing in the development of precision live biotherapeutic products (LBPs) with lead products in immuno-oncology and inflammatory bowel disease. The company leverages a genomics-driven microbiome platform to identify bacterial strains associated with favorable clinical outcomes, enabling the discovery and development of novel therapeutic products. They aim to deliver safe and precise microbiome medicines to benefit patients.

## Key facts

- **Slug:** microbiotica
- **Website:** https://microbiotica.com
- **Location:** Cambridge, United Kingdom
- **Founded:** 2016-01-01
- **Employees:** 49
- **Operating status:** Active
- **Total funding:** $112M
- **Sectors / tags:** Biopharma, Biotechnology, Life Sciences, Healthcare, Biotech
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/microbiotica-limited

## StartupHub.ai scores

- **Ahrefs DR:** 34/100
- **Effective DR:** 20/100
- **Agent Readiness:** D (41/100)
- **Site Speed:** 78/100
- **Data Trust:** 67/100

## Funding rounds

| Date | Round | Amount | Lead investors |
| --- | --- | --- | --- |
| 1 Oct 2026 | [Series C](https://www.startuphub.ai/investment_rounds/microbiotica-series-c-2026) | $45M | [British Business Bank](https://www.startuphub.ai/investors/british-business-bank) |
| 7 Mar 2022 | [Series B](https://www.startuphub.ai/investment_rounds/microbiotica-series-b-2022) | $67M | [Tencent](https://www.startuphub.ai/investors/tencent) |

## Tech stack

Detected on microbiotica.com, last scanned 2026-10-16.

- **Frontend:** jQuery
- **Analytics:** Jetpack / WP.com Stats
- **CMS / Builders:** WordPress
- **Email provider:** Microsoft 365
- **Cookie consent:** Cookiebot
- **Video / media:** YouTube

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Microbiotica",
          "item": "https://www.startuphub.ai/startups/microbiotica"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/microbiotica#webpage",
      "url": "https://www.startuphub.ai/startups/microbiotica",
      "name": "Microbiotica - AI Startup Profile | StartupHub.ai",
      "description": "This is the StartupHub.ai profile of Microbiotica. Microbiotica is a startup founded in 2016, operating in Biopharma and Biotechnology. British clinical-stage biopharma company developing a pipeline of orally-dosed, precision microbiome medicines. Headquartered in Cambridge, United Kingdom. The company has approximately 49 employees.",
      "dateModified": "2026-10-16T11:42:58.443Z",
      "mainEntity": {
        "@type": "Organization",
        "@id": "https://www.startuphub.ai/startups/microbiotica#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/microbiotica#organization",
      "name": "Microbiotica",
      "url": "https://microbiotica.com",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/3ae20b9c-962f-4198-b2cc-fb1ad4d59182-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/3ae20b9c-962f-4198-b2cc-fb1ad4d59182-square.webp",
      "description": "Microbiotica is a clinical-stage biopharmaceutical company specializing in the development of precision live biotherapeutic products (LBPs) with lead products in immuno-oncology and inflammatory bowel disease. The company leverages a genomics-driven microbiome platform to identify bacterial strains associated with favorable clinical outcomes, enabling the discovery and development of novel therapeutic products. They aim to deliver safe and precise microbiome medicines to benefit patients.",
      "sameAs": [
        "https://www.linkedin.com/company/microbiotica-limited"
      ],
      "foundingDate": "2016-01-01",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 49
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Cambridge",
        "addressCountry": "GB"
      },
      "knowsAbout": [
        "Biopharma",
        "Biotechnology",
        "Life Sciences",
        "Healthcare",
        "Biotech"
      ]
    }
  ]
}
```